Andrew Guggenhime

Andrew Guggenhime

Director Financiero/CFO en VAXCYTE, INC. .

Fortuna: 9 M $ al 31/05/2026

57 años
Health Technology
Finance
Consumer Services

Perfil

Mr. Andrew L.
Guggenhime
is a Chairman at Caribou Biosciences, Inc. and a President & Chief Financial Officer at Vaxcyte, Inc. Mr. Guggenhime was previously employed as an Independent Director by Metacrine, Inc., a Chief Financial Officer by Dermira, Inc., a Chief Financial Officer by Calistoga Pharmaceuticals, Inc., a Chief Financial Officer & Senior Vice President by Abbott Biotherapeutics Corp., a Chief Financial Officer & Senior Vice President by PDL BioPharma, Inc., a Chief Financial Officer & Senior Vice President by Neoforma, Inc., a Vice President by Merrill Lynch & Co., Inc., and an Assistant VP-Real Estate Capital Markets Group by Wells Fargo & Co. He also served on the board at CardioDx, Inc. He received his undergraduate degree from Middlebury College and an MBA from Kellogg School of Management.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
06/07/2026 166.245 ( 0,12 % ) 9 M $ 31/05/2026
20/04/2026 0 ( -.--% ) - $ 31/05/2026

Cargos activos de Andrew Guggenhime

EmpresasCargoInicio
VAXCYTE, INC. Director Financiero/CFO 01/05/2020
CARIBOU BIOSCIENCES, INC. Presidente 01/07/2021

Antiguos cargos conocidos de Andrew Guggenhime.

EmpresasCargoFin
METACRINE, INC. Director/Miembro de la Junta 23/03/2023
DERMIRA, INC. Director Financiero/CFO 01/05/2020
CARDIODX INC Director Financiero/CFO 28/04/2014
Director Financiero/CFO 01/04/2011
Director Financiero/CFO 01/06/2010
Ver el detalle de la experiencia de Andrew Guggenhime.

Formación de Andrew Guggenhime.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

66

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Finance

Distribution Services

Health Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Andrew Guggenhime